Peptide-Functionalized Lipid Nanoparticles for Targeted Systemic mRNA Delivery to the Brain.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 39688915.
- Also identified by DOI 10.1021/acs.nanolett.4c05186.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Systemic delivery of large nucleic acids, such as mRNA, to the brain remains challenging in part due to the blood-brain barrier (BBB) and the tendency of delivery vehicles to accumulate in the liver. Here, we design a peptide-functionalized lipid nanoparticle (LNP) platform for targeted mRNA delivery to the brain. We utilize click chemistry to functionalize LNPs with peptides that target receptors overexpressed on brain endothelial cells and neurons, namely the RVG29, T7, AP2, and mApoE peptides. We evaluate the effect of LNP targeting on brain endothelial and neuronal cell transfection <i>in vitro</i>, investigating factors such as serum protein adsorption, intracellular trafficking, endothelial transcytosis, and exosome secretion. Finally, we show that LNP peptide functionalization enhances mRNA transfection in the mouse brain and reduces hepatic delivery after systemic administration. Specifically, RVG29 LNPs improved neuronal transfection <i>in vivo</i>, establishing its potential as a nonviral platform for delivering mRNA to the brain.
Medical subject headings
- Nanoparticles
- RNA, Messenger
- Brain
- Lipids
- Peptides